Ambee Pharmaceuticals Statistics

Total Valuation

DSE:AMBEEPHA has a market cap or net worth of BDT 1.80 billion. The enterprise value is 2.31 billion.

Market Cap	1.80B
Enterprise Value	2.31B

Important Dates

The last earnings date was Monday, January 27, 2025.

Earnings Date	Jan 27, 2025
Ex-Dividend Date	Dec 3, 2024

Share Statistics

DSE:AMBEEPHA has 2.40 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	2.40M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	77.25%
Owned by Institutions (%)	n/a
Float	545,941

Valuation Ratios

The trailing PE ratio is 181.29.

PE Ratio	181.29
Forward PE	n/a
PS Ratio	7.97
PB Ratio	59.76
P/TBV Ratio	59.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 128.87, with an EV/FCF ratio of -20.90.

EV / Earnings	231.81
EV / Sales	10.19
EV / EBITDA	128.87
EV / EBIT	185.37
EV / FCF	-20.90

Financial Position

The company has a current ratio of 0.92, with a Debt / Equity ratio of 20.83.

Current Ratio	0.92
Quick Ratio	0.47
Debt / Equity	20.83
Debt / EBITDA	35.13
Debt / FCF	-5.70
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 37.67% and return on invested capital (ROIC) is 1.41%.

Return on Equity (ROE)	37.67%
Return on Assets (ROA)	1.22%
Return on Invested Capital (ROIC)	1.41%
Return on Capital Employed (ROCE)	35.58%
Revenue Per Employee	427,780
Profits Per Employee	18,812
Employee Count	529
Asset Turnover	0.36
Inventory Turnover	0.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.18% in the last 52 weeks. The beta is -0.19, so DSE:AMBEEPHA's price volatility has been lower than the market average.

Beta (5Y)	-0.19
52-Week Price Change	-3.18%
50-Day Moving Average	712.60
200-Day Moving Average	773.61
Relative Strength Index (RSI)	63.64
Average Volume (20 Days)	1,709

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, DSE:AMBEEPHA had revenue of BDT 226.30 million and earned 9.95 million in profits. Earnings per share was 4.15.

Revenue	226.30M
Gross Profit	121.43M
Operating Income	12.44M
Pretax Income	12.95M
Net Income	9.95M
EBITDA	17.90M
EBIT	12.44M
Earnings Per Share (EPS)	4.15

Full Income Statement

Balance Sheet

The company has 126.15 million in cash and 628.89 million in debt, giving a net cash position of -502.74 million or -209.48 per share.

Cash & Cash Equivalents	126.15M
Total Debt	628.89M
Net Cash	-502.74M
Net Cash Per Share	-209.48
Equity (Book Value)	30.19M
Book Value Per Share	12.58
Working Capital	-55.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -99.35 million and capital expenditures -11.00 million, giving a free cash flow of -110.35 million.

Operating Cash Flow	-99.35M
Capital Expenditures	-11.00M
Free Cash Flow	-110.35M
FCF Per Share	-45.98

Full Cash Flow Statement

Margins

Gross margin is 53.66%, with operating and profit margins of 5.50% and 4.40%.

Gross Margin	53.66%
Operating Margin	5.50%
Pretax Margin	5.72%
Profit Margin	4.40%
EBITDA Margin	7.91%
EBIT Margin	5.50%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 1.00, which amounts to a dividend yield of 0.13%.

Dividend Per Share	1.00
Dividend Yield	0.13%
Dividend Growth (YoY)	-33.33%
Years of Dividend Growth	n/a
Payout Ratio	57.95%
Buyback Yield	n/a
Shareholder Yield	0.13%
Earnings Yield	0.55%
FCF Yield	-6.12%

Dividend Details

Stock Splits

The last stock split was on May 29, 2014. It was a forward split with a ratio of 1.2.

Last Split Date	May 29, 2014
Split Type	Forward
Split Ratio	1.2

Scores

DSE:AMBEEPHA has an Altman Z-Score of 1.88. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.88
Piotroski F-Score	n/a